These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 17558391)

  • 1. 'Rejuvenation' protects neurons in mouse models of Parkinson's disease.
    Chan CS; Guzman JN; Ilijic E; Mercer JN; Rick C; Tkatch T; Meredith GE; Surmeier DJ
    Nature; 2007 Jun; 447(7148):1081-6. PubMed ID: 17558391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurophysiology: stressful pacemaking.
    Bean BP
    Nature; 2007 Jun; 447(7148):1059-60. PubMed ID: 17597746
    [No Abstract]   [Full Text] [Related]  

  • 3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A molecular basis for the increased vulnerability of substantia nigra dopamine neurons in aging and Parkinson's disease.
    Chan CS; Gertler TS; Surmeier DJ
    Mov Disord; 2010; 25 Suppl 1():S63-70. PubMed ID: 20187241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What causes the death of dopaminergic neurons in Parkinson's disease?
    Surmeier DJ; Guzman JN; Sanchez-Padilla J; Goldberg JA
    Prog Brain Res; 2010; 183():59-77. PubMed ID: 20696315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.
    Damier P; Hirsch EC; Agid Y; Graybiel AM
    Brain; 1999 Aug; 122 ( Pt 8)():1437-48. PubMed ID: 10430830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium, cellular aging, and selective neuronal vulnerability in Parkinson's disease.
    Surmeier DJ; Guzman JN; Sanchez-Padilla J
    Cell Calcium; 2010 Feb; 47(2):175-82. PubMed ID: 20053445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1.
    Guzman JN; Sanchez-Padilla J; Wokosin D; Kondapalli J; Ilijic E; Schumacker PT; Surmeier DJ
    Nature; 2010 Dec; 468(7324):696-700. PubMed ID: 21068725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium, ageing, and neuronal vulnerability in Parkinson's disease.
    Surmeier DJ
    Lancet Neurol; 2007 Oct; 6(10):933-8. PubMed ID: 17884683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
    Surmeier DJ; Guzman JN; Sanchez-Padilla J; Schumacker PT
    Neuroscience; 2011 Dec; 198():221-31. PubMed ID: 21884755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.
    Surmeier DJ; Halliday GM; Simuni T
    Exp Neurol; 2017 Dec; 298(Pt B):202-209. PubMed ID: 28780195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for neurogenesis in the adult mammalian substantia nigra.
    Zhao M; Momma S; Delfani K; Carlen M; Cassidy RM; Johansson CB; Brismar H; Shupliakov O; Frisen J; Janson AM
    Proc Natl Acad Sci U S A; 2003 Jun; 100(13):7925-30. PubMed ID: 12792021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium homeostasis, selective vulnerability and Parkinson's disease.
    Chan CS; Gertler TS; Surmeier DJ
    Trends Neurosci; 2009 May; 32(5):249-56. PubMed ID: 19307031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease.
    Corona JC; Gimenez-Cassina A; Lim F; Díaz-Nido J
    J Neurosci Res; 2010 Jul; 88(9):1943-50. PubMed ID: 20143419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta.
    Eriksen N; Stark AK; Pakkenberg B
    J Neural Transm Suppl; 2009; (73):203-13. PubMed ID: 20411779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial loss of dopaminergic neurons in the substantia nigra, ventrotegmental area and the retrorubral area -- model of the early beginning of Parkinson's symptomatology?
    Heim C; Sova L; Kurz T; Kolasiewicz W; Schwegler H; Sontag KH
    J Neural Transm (Vienna); 2002 May; 109(5-6):691-709. PubMed ID: 12111461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel role of aquaporin-4 in CD4+ CD25+ T regulatory cell development and severity of Parkinson's disease.
    Chi Y; Fan Y; He L; Liu W; Wen X; Zhou S; Wang X; Zhang C; Kong H; Sonoda L; Tripathi P; Li CJ; Yu MS; Su C; Hu G
    Aging Cell; 2011 Jun; 10(3):368-82. PubMed ID: 21255222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute action of rotenone on nigral dopaminergic neurons--involvement of reactive oxygen species and disruption of Ca2+ homeostasis.
    Freestone PS; Chung KK; Guatteo E; Mercuri NB; Nicholson LF; Lipski J
    Eur J Neurosci; 2009 Nov; 30(10):1849-59. PubMed ID: 19912331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic reduction of mitochondrial complex I function does not lead to loss of dopamine neurons in vivo.
    Kim HW; Choi WS; Sorscher N; Park HJ; Tronche F; Palmiter RD; Xia Z
    Neurobiol Aging; 2015 Sep; 36(9):2617-27. PubMed ID: 26070241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.